HER2-positive Carcinoma
2 clinical trials · Condition
◉ Watch HER2-positive Carcinoma
| Record | Firm | Date |
|---|---|---|
| Imaging With a New Agent That Finds a Cancer Protein Called HER2 (NCT03109977) | Memorial Sloan Kettering Cancer Center | 2017-03-31 |
| Margetuximab Expanded Access Program (NCT03133988) | TerSera Therapeutics LLC |
Track HER2-positive Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.